1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 11 Hits
  • 検索条件 : 絞込み (MeSH = Biliary Tract Neoplasms / drug therapy*)
生物種 リソース名 タイトル
ヒト・動物細胞 HuCCT1(RCB1960) , TFK-1(RCB2537) ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer.
ヒト・動物細胞 RBE(RCB1292) , TFK-1(RCB2537) Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer.
ヒト・動物細胞 HuCCT1(RCB1960) , TFK-1(RCB2537) Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer.
ヒト・動物細胞 TKKK(RCB1907) , TGBC2TKB(RCB1130) , TGBC18TKB(RCB1169) , TGBC14TKB(RCB1186) , G-415(RCB2640) , HuCCT1(RCB1960) K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
ヒト・動物細胞 TGBC2TKB(RCB1130) , TGBC14TKB(RCB1186) , TGBC24TKB(RCB1196) , TGBC18TKB(RCB1169) , TGBC50TKB(RCB1280) , TGBC51TKB(RCB1281) , TGBC52TKB(RCB1282) Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.
ヒト・動物細胞 HuCCT1(RCB1960) , TFK-1(RCB2537) Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
ヒト・動物細胞 HuCCT1(RCB1960) Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
ヒト・動物細胞 TKKK(RCB1907) , TGBC24TKB(RCB1196) , HuCCT1(RCB1960) PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.
ヒト・動物細胞 TFK-1(RCB2537) A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
ヒト・動物細胞 TGBC1TKB(RCB1129) Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
ヒト・動物細胞 TKKK(RCB1907) , TGBC24TKB(RCB1196) , HuCCT1(RCB1960) Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.